A Multinational, Multicenter, Observational, Exposure Registry Study to Compare the Birth Defects in Teriflunomide Treated Pregnant Women with Those Reported by European Surveillance of Congenital Anomalies (EUROCAT)

Trial Profile

A Multinational, Multicenter, Observational, Exposure Registry Study to Compare the Birth Defects in Teriflunomide Treated Pregnant Women with Those Reported by European Surveillance of Congenital Anomalies (EUROCAT)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Aug 2015

At a glance

  • Drugs Teriflunomide (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Aug 2015 New trial record
    • 20 Jun 2015 Trial design presented at 1st Congress of the European Academy of Neurology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top